Salipro Biotech announces yet another research collaboration

Salipro Biotech has entered into yet another research collaboration agreement with a Gene Therapy Biotech company in the USA. Within this new collaboration, the Salipro® platform will be used to evaluate therapeutic antibodies to improve cell-based gene therapies. 

We look forward to the advancements this project will contribute to our core mission: making the undruggable druggable.

Next
Next

Salipro Biotech announces a new research collaboration